Trials / Completed
CompletedNCT01499342
Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery
Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent to Treat Atherosclerotic Lesions in the Superficial Femoral Artery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 435 (actual)
- Sponsor
- be Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Belgian prospective multicentre registry to evaluate safety and performance of the Sinus-Superflex-Visual stent (Optimed) in Superficial Femoral Artery (SFA) atherosclerotic lesions. Target number is 500 patients in approximately 11 centres. Patients will be followed for a period of 2 years.
Conditions
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2011-12-26
- Last updated
- 2022-08-22
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01499342. Inclusion in this directory is not an endorsement.